1ST Biotherapeutics, Inc.
PrivateLast Round
Series D
Jan 26, 2026
Total Funding Raised
$83.17M
Company Overview
1ST Biotherapeutics, Inc. is a biopharmaceutical company that develops a pipeline of investigational drugs for immuno-oncology, neurodegenerative diseases, and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
1ST Biotherapeutics, Inc. Comps
Public and private peers based on sector, stage, and business model.
1ST Biotherapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 26, 2026 | ||||
| Series C Extension | Jul 14, 2023 | ||||
| VC Round | Jul 30, 2020 | ||||
| Series B | Apr 17, 2018 | ||||
| Series A | Nov 30, 2016 |
1ST Biotherapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Woori Investment & Securities | Series D |
| InterVest | Series B |
| LigaChem Biosciences | Series D |
| BNH INVESTMENT | Series B |
| CKD Venture Capital | Series D |
| Smilegate Investment | VC Round, Series D |
| KB Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
$22M round led by Groom Investment and Smilegate Investment.
1ST Biotherapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about 1ST Biotherapeutics, Inc.'s valuation, stock price, and market status.
